Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rishena has developed an implantable vagus nerve stimulator that has been approved for market in China. Other products, including implantable gastric/colon stimulators, spinal cord stimulators, and closed-loop brain stimulation devices for neurological diseases like epilepsy and Parkinson’s disease are at various stages of clinical development with multi-center trials ongoing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rishena Medical.